FIELD: medicine.
SUBSTANCE: method involves carrying out conventional mice hyperimmunization of BAlb/c for producing polarized lymphocytes with three-fold subcutaneous ovalbumin introduction at a dose of 100 mcg/mouse and aluminum hydroxide adjuvant introduction at a dose of 5 mg/mouse making 14 days long pause between injections. Spleens are taken and lymphocytes are separated 7 days later after the last injection.
EFFECT: simplified method for obtaining polarized TH-2 lymphocytes in the amount for modeling immune response of TH-2 type.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF MYCOBACTERIUM VACCAE FOR FEEDBACK INHIBITION REGULATION OF TH2-ACTIVITY OF IMMUNE SYSTEM | 1997 |
|
RU2197989C2 |
| ANTIALLERGIC AGENT | 2008 |
|
RU2378004C1 |
| DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
| ADJUVANT | 2020 |
|
RU2736933C1 |
| AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2734420C1 |
| AGENT ELICITING ANTI-ALLERGIC EFFECT | 2003 |
|
RU2240801C1 |
| AGENT BASED ON WATER-SOLUBLE VEGETABLE POLYSACCHARIDES, HAVING ANTIALLERGIC ACTIVITY | 2023 |
|
RU2823873C1 |
| IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
| MICROFLUIDIZED COMPOSITION FOR INDUCTION OF SPECIFIC CYTOTOXIC T-LYMPHOCYTE IMMUNE RESPONSE AND ITS USING FOR DISEASE TREATMENT | 1995 |
|
RU2201253C2 |
| METHOD FOR OBTAINING VACCINE FOR TREATING TUBERCULOSIS AND OTHER INTRACELLULAR INFECTIOUS DISEASES AND VACCINE OBTAINED ACCORDING TO DECLARED METHOD | 2001 |
|
RU2262950C2 |
